Skip to content

Clareon CNW0T6 (UDI 00380652411264)Recalls & reported problems

Alcon Laboratories, Inc. · CLAREON BLF TORIC · Class 3 · Implant

All models of Clareon (1142)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00380652411264), received between Jan 12, 2026 and Jan 12, 2026 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Material Split, Cut or Torn” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 2 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Material Split, Cut or Torn2

Patient problems

  • Insufficient Information2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 12, 2026Material Split, Cut or Torn

    A NURSE REPORTED THAT DURING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, WITH THESE TWO IOL¿S, THEY WERE LOADED BY TWO DIFFERENT TECHS, WITH A DIFFERENT CARTRIDGE, AND A DIFFERENT INJECTOR EACH TIME (IN THE SAME PATIENT). THEY WERE PERFORMED ON THE SAME PATIENT, USING THE SAME ( TORIC & SPHERE) IOL POWER & MODEL WITH, I BELIEVE, THE SAME REFERENCE NUMBERS. AS THEY DIDN¿T HAVE A THIRD IOL OF THAT POWER, THEY OBTAINED A PRELOADED TORIC IOL OF THE SAME POWER BUT THE COLORLESS VERSION. ON THE INITIAL ATTEMPT TO PLACE IN THE PATIENT, IT WAS INADVERTENTLY INJECTED OUTSIDE OF THE PATIENT¿S EYE. THEREFORE, IT HAD TO BE MANUALLY LOADED AND THEN INJECTED WHICH PROCEEDED UNEVENTFULLY. THE FIRST IOL HAD THE TIP OF THE OF THE LEADING HAPTIC TRUNCATED OFF, THE TRAILING HAPTIC BROKE SUCH THAT TWO SEPARATE PIECES OF THE HAPTIC BROKE OFF, AND THE EDGE OF THE IOL OPTIC AND SURFACE OF THE IOL HAD SOME DAMAGE. THE SECOND IOL INJECTED, AND THE OPTIC WAS CUT NEARLY COMPLETELY IN HALVES DOWN THE MIDDLE OF THE OPTIC. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: Insufficient Information

    MAUDE report 24043638 ↗
  • MalfunctionJan 12, 2026Material Split, Cut or Torn

    A NURSE REPORTED THAT DURING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, WITH THESE TWO IOL¿S, THEY WERE LOADED BY TWO DIFFERENT TECHS, WITH A DIFFERENT CARTRIDGE, AND A DIFFERENT INJECTOR EACH TIME (IN THE SAME PATIENT). THEY WERE PERFORMED ON THE SAME PATIENT, USING THE SAME ( TORIC & SPHERE) IOL POWER & MODEL WITH, I BELIEVE, THE SAME REFERENCE NUMBERS. AS THEY DIDN'T HAVE A THIRD IOL OF THAT POWER, THEY OBTAINED A PRELOADED TORIC IOL OF THE SAME POWER BUT THE COLORLESS VERSION. ON THE INITIAL ATTEMPT TO PLACE IN THE PATIENT, IT WAS INADVERTENTLY INJECTED OUTSIDE OF THE PATIENT¿S EYE. THEREFORE, IT HAD TO BE MANUALLY LOADED AND THEN INJECTED WHICH PROCEEDED UNEVENTFULLY. THE FIRST IOL HAD THE TIP OF THE OF THE LEADING HAPTIC TRUNCATED OFF, THE TRAILING HAPTIC BROKE SUCH THAT TWO SEPARATE PIECES OF THE HAPTIC BROKE OFF, AND THE EDGE OF THE IOL OPTIC AND SURFACE OF THE IOL HAD SOME DAMAGE. THE SECOND IOL INJECTED, AND THE OPTIC WAS CUT NEARLY COMPLETELY IN HALVES DOWN THE MIDDLE OF THE OPTIC. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: Insufficient Information

    MAUDE report 24043614 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page